Drug Discovery Today: TARGETS

Titel Veröffentlichungsdatum Sprache Zitate
Analysis of large-scale MS data sets: the dramas and the delights2004/04/01English1
In silico predictions of target clinical efficacy2004/10/01English1
Patent Update2004/02/01English
Microarray technology: an increasing variety of screening tools for proteomic research2004/02/01English
High-throughput technologies for studying potassium channels – progresses and challenges2004/02/01English
Just how normal is normal?2004/02/01English
Climbing Mount Everest, the GPCR way2004/02/01English
Gene therapy crosses the species barrier2004/02/01English
Comparing genomes2004/02/01English
Ribozymes in gene identification, target validation and drug discovery2004/02/01English
A new title for TARGETS in 20042004/02/01English
Patent News2004/02/01English
From functional genomics to target validation: the quest for better drugs2004/02/01English
Fold recognition for drug discovery2004/02/01English
Target-based compound library design and synthesis2004/04/01English
Taming of the polyQ2004/04/01English
Translational genomics: safeguarding patient privacy and harnessing the genomic revolution in medicine2004/04/01English
Patent Strategy (part 2)2004/04/01English
Patent News2004/04/01English
The price of purifying proteins2004/04/01English
Unraveling the human interactome: lessons from the yeast2004/04/01English
Yeast gets humanized2004/04/01English
Quality analysis and integration of large-scale molecular data sets2004/04/01English
Targets for Alzheimer's disease: lessons learnt from flies2004/04/01English
New genetic strategies for protein discovery based on whole-genome sequences2004/04/01English
Moonlighting proteins: complications and implications for proteomics research2004/04/01English
Are drugs discovered in the clinic or the laboratory?2004/10/01English
Christophe Echeverri: from Canada to Cenix2004/10/01English
Functional pharmacology: the drug discovery bottleneck?2004/10/01English
Evolvability: implications for drug design2004/10/01English